ELAVL1 and hepatocellular carcinoma: Importantly, the expressional changes of some RBPs, including HuR (ELAVL1) and PTBP1, are aberrantly expressed and co-related with the prognosis of ovarian and hepatocellular carcinoma patients [7,8].